External reports (aggregated public sources), Value Investors Club

Value Investors Club

Value Investors Club (.com) is an exclusive online investment club where top investors share their best ideas. Content available at the above link/PDF preview is an external article authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External reports (aggregated public sources)

Equity Bottom-Up

<ul><li>Acasti Pharma is making progress in developing IV nimodipine for acute subarachnoid hemorrhages</li><li>Lead asset GTX-104 is the primary focus of their development efforts</li><li>Successful PIPE offering and enrollment in Phase 3 trial put Acasti Pharma on track for potential FDA approval</li></ul><p><em>This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.</em></p>

Acasti Pharma is making progress in developing IV nimodipine for acute subarachnoid hemorrhagesLead asset GTX-104 is the primary focus of their development effortsSuccessful PIPE offering and enrollment in Phase 3 trial put Acasti Pharma on track for potential FDA approvalThis content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Acasti Pharma Inc (ACST) - Wednesday, Jul 10, 2024

Grace Therapeutics

Acasti Pharma Inc (ACST) - Wednesday, Jul 10, 2024